# US 2009/0221835 A1 · Processes for preparing biaryl ureas and analogs thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0221835 A1
- Document ID: US20090221835A1
- Status: Published application
- Kind: A1
- Application number: 12/435,646
- Filed: 2009-05-05
- Published: 2009-09-03
- Earliest claimed: 2005-05-09
- Assignees: Vertex Pharmaceuticals Incorporated
- Inventors: Graham Ansell; Todd Blythe; Andrew Jones; Benjamin Littler; Adam Looker; Philip Nyce; John Snoonian
- Web page: https://patentgrep.com/patent/US20090221835A1

## CPC

- C07D 307/20: Oxygen atoms
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to processes for preparing biaryl ureas derivatives and analogs thereof. The invention also provides compounds useful as intermediates in the processes of the present invention. The process is useful for preparing compounds that inhibit IMPDH.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A process for preparing a compound of formula II:
comprising the steps of:
(a) converting a compound of formula V:
under suitable catalytic hydrogenation conditions to give a compound of formula IV:
or a salt thereof, and
(b) reacting said compound of formula IV with a compound of formula LGC(O)X1, under suitable conditions, wherein:
X1 is a halogen;
LG is —OR16; wherein R16 is —(C1-C6)-straight or branched alkyl; —(C2-C6)-straight or branched alkenyl or alkynyl; or a monocyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 3 heteroatoms selected from N, O, or S, and each R16 optionally comprises up to 5 substituents independently selected from (C1-C4)-straight or branched alkyl, (C2-C4) straight or branched alkenyl, or (CH2)n-Z;
wherein Z is selected from halogen, CN, NO2, CF3, OCF3, OH, S(C1-C4)-alkyl, SO(C1-C4)-alkyl, SO2(C1-C4)-alkyl, NH2, NH(C1-C4)-alkyl, N((C1-C4)-alkyl)2, COOH, C(O)O(C1-C4)-alkyl or O(C1-C4)-alkyl;
n is 0, 1, 2, 3, or 4;
y is zero;
R1 or R2 is selected from hydrogen, methyl ethyl or phenyl; and the other of R1 or R2 is selected from —CH2OH, —CH2CN, —CH2CH CN, or —CH2N(CH2CH3)2; or wherein R1 and R2 are taken together to form a 3-tetrahydrofuranyl moiety;
R9 is hydrogen, (S)-methyl, (S)-ethyl or (S)-hydroxymethyl;
R10 is selected from —C≡N or 5-oxazolyl;
R11 is methoxy, ethoxy or isopropoxy;
each V1 is independently selected from halogens NO2, CN, OR12, OC(O)R13, OC(O)R12, OC(O)OR13, OC(O)OR12, OC(O)N(R13)2, OP(O)(OR13)2 SR13, SR12, S(O)R13, S(O)R12, SO2R13, SO2R12, SO2N(R13)2, SO2NR12R13, SO3R13, C(O)R12, C(O)OR12C(O)R13, C(O)OR13, NC(O)C(O)R13, NC(O)C(O)R12, NC(O)C(O)OR13, NC(O)C(O)N(R13)2, C(O)N(R13)2, C(O)N(OR13)R13, C(O)N(OR13)R13, C(NOR12)R13COR13)R13, N(R12, N(R13)2, NR13C(O)R12, NR13C(O)R13, NR13C(O)R12NR13, C(O)OR13NR13C(O)OR12, NR13C(O)N(R13)2, NR13C(O)NR12R13, NR13SO2R13, NR13SO2R12, NR13SO2N(R13)2, NR13SO2R12R13, N(OR)R13, N(OR13)R12, P(O)(OR13)N(R13)2, and P(O)(OR13)2;
wherein each R12 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O, or S, and wherein a CH2 adjacent to said N, O or S may be substituted with C(O); and each R12 optionally comprises up to 3 substituents selected from R11;
wherein each R13 is independently selected from H, (C1-4)-straight or branched alkyl or (C2-C4) straight or branched alkenyl; and
wherein each R13 optionally comprises a substituent that is R14;
wherein R14 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O or S, and wherein a CH2 adjacent to said N, O or S maybe substituted with C(O); and each R14 optionally comprises up to 2 substituents independently chosen from H, (C1-C4)-straight or branched alkyl or (C2-C4) straight or branched alkenyl 1,2-methylenedioxy, 1,2-ethylenedioxy, or (CH2)n-Z;
wherein Z is selected from halogen CN, N2, CF3 oCF3, OH, S(C1-C4) alkyl, SO(C1-C4)-alkyl SO2(C1-C4)-alkyl NH2, NH(C1-C4-alkyl N((C1-C4)-alkyl)2, COOH, C(O)O(C1-C4)-alkyl or O(C1-C4)-alkyl; and
wherein any carbon atom in any R13 is optionally replaced by O, S, SO, SO2 NH, or N(1-C4)-alkyl; and
provided that R16 is not a halo-substituted (C2-C3)-straight alkyl.

### Claim 23 (depends on 22)

The process according to claim 22, wherein:
in step (a) said suitable hydrogenation conditions comprise one or more of the following: a suitable metal catalyst; a suitable solvent selected from a protic solvent, a polar aprotic solvent, a non-polar aprotic solvent or any mixtures thereof; a suitable reaction atmosphere of hydrogen gas at a suitable pressure; and a suitable reaction temperature; and
in step (b) said suitable conditions for reacting said intermediate of formula IV with a compound of formula LGC(O)X1 comprises one or more of the following: a suitable solvent selected from a protic solvent, an aprotic solvent or mixtures thereof; a suitable inorganic or organic base; a suitable reaction atmosphere; and a suitable reaction temperature.

### Claim 24 (depends on 23)

The process according to claim 23, wherein said process comprises one or more of the following:
in step (a) said metal catalyst is between about 1% to about 30% by weight palladium metal on carbon; said protic solvent is selected from a (C1-C5)-straight or branched alkyl alcohol; said aprotic solvent is selected from an ester-type solvent; said reaction atmosphere comprises hydrogen gas at between about one to about ten atmospheres of pressure; and said reaction temperature is between about 20° C. to about 60° C.; and
in step (b) said suitable solvent is a mixture of water and an aprotic solvent selected from ethyl acetate, isopropyl acetate, n-butyl acetate, benzene, toluene, xylene, dichloromethane, dichloroethane, chloroform, trifluorotoluene, ethyl ether, isopropyl ether, or methyl t-butyl ether; said reaction atmosphere is selected from air, nitrogen or argon; and said reaction temperature is between about 20° C. and about 80° C.

### Claim 25 (depends on 24)

The process according to claim 24, wherein said process comprises one or more of the following:
(a) said metal catalyst is between about 5% to about 10% by weight palladium metal on carbon; said protic solvent is selected from methanol, ethanol, or isopropanol; said aprotic solvent is selected from ethyl acetate or isopropyl acetate; said reaction atmosphere of hydrogen gas is between about one to about eight atmospheres of pressure; and said reaction temperature is between about 20° C. to about 40° C.; and
(b) said suitable solvent is a mixture of water and an aprotic solvent selected from ethyl acetate or isopropyl acetate;
said reaction atmosphere is selected from nitrogen or argon; said inorganic base is selected from Na2SO4; and said reaction temperature is between about 40° C. and about 60° C.

### Claim 26 (depends on 25)

The process according to claim 25, wherein:
(a) said metal catalyst is about 5% by weight palladium metal on carbon; said aprotic solvent is ethyl acetate; said reaction atmosphere of hydrogen gas is between about four and eight atmospheres of pressure; and said reaction temperature is between about 20° C. to about 30° C.; and
(b) said suitable solvent is a mixture of water and an aprotic solvent selected from ethyl acetate or isopropyl acetate; said reaction atmosphere is selected from nitrogen; and said reaction temperature is between about 40° C. and about 60° C.

### Claim 27 (depends on 22)

The process according to claim 22, wherein:
R16 is a monocyclic ring system consisting of 6 members per ring, wherein said ring system optionally comprises up to 2 heteroatoms selected from N, O, or S, and each R16 optionally comprises up to 5 substituents independently selected from (C1-C4)-straight or branched alkyl, or (CH2)n-Z.

### Claim 28 (depends on 27)

The process according to claim 27, wherein:
R16 is a phenyl ring optionally comprising up to 5 substituents independently selected from (C1-C4)-straight or branched alkyl, or (CH2)n-Z.

### Claim 29 (depends on 28)

The process according to claim 28, wherein R16 is a phenyl ring.

### Claim 30 (depends on 22)

The process according to claim 22, wherein:
R1 and R2 are taken together to form a 3-tetrahydrofuranyl ring; and
R9 is hydrogen.

### Claim 31

(canceled)

### Claim 32 (depends on 22)

The process according to claim 22, wherein:
R1 or R2 is ethyl; and the other of R1 or R2 is —CH2CN; and
R9 is (S)-methyl.

### Claim 33 (depends on 22)

The process according to claim 22, wherein said compound of formula V:
is prepared by a process comprising the steps of:
(a) reacting a compound of formula VII with a phosgene reagent or a suitable phosgene reagent equivalent, under suitable conditions, to prepare a compound of formula VIII;
(b) reacting said compound of formula VIII, or a synthetically acceptable analog or derivative thereof, with a compound of formula IX, or a synthetically acceptable analog or derivative thereof, under suitable conditions:
wherein:
X1 is halogen;
y is zero;
R1 or R2 is selected from hydrogen, methyl, ethyl or phenyl; and the other of R1 or R2 is selected from —CH2OH, —CH2CN, —CH2CH2CN, or —CH2N(CH2CH3)2; or wherein R1 and R2 are taken together to form a 3-tetrahydrofuranyl moiety;
R9 is hydrogen, (S)-methyl, (S)-ethyl, or (S)-hydroxymethyl;
each V1 is independently selected from halogen, NO2, CN, OR12, OC(O)R13, OC(O)R12, OC(O)OR13, OC(O)OR12, OC(O)N(R13)2, OP(O)(OR13)2, SR13, SR12, S(O)R13, S(O)R12, SO2R13, SO2R12, SO2N(R13)2, SO2NR13R12, SO3R13, C(O)R13, C(O)OR12, C(O)R13, C(O)OR13, NC(O)C(O)R13, NC(O)C(O)R12, NC(O)C(O)OR13, NC(O)C(O)N(R13)2, C(O)N(R13)2, C(O)N(OR13)R13, C(O)N(OR13)R13, C(NOR13)R13, C(NOR13)R12, N(R13)2, NR13C(O)R12, NR13C(O)R13, NR13C(O)R12, NR13C(O)OR13, NR13C(O)OR12, NR13C(O)N(R13)2, NR13C(O)NR12R13, NR13SO2R13, NR13SO2R12, NR13SO2N(R13)2, NR13SO2NR12R13, N(OR13)R13, N(OR13)R12, P(O)(OR13)N(R13)2, and P(O)(OR13)2;
wherein each R12 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O, or S, and wherein a CH2 adjacent to said N, O or S may be substituted with C(O); and each R12 optionally comprises up to 3 substituents selected from R11;
wherein each R13 is independently selected from H, (C1-C4)-straight or branched alkyl, or (C2-C4) straight or branched alkenyl; and
wherein each R13 optionally comprises a substituent that is R14;
wherein R14 is a monocyclic or a bicyclic ring system consisting of 5 to 6 members per ring, wherein said ring system optionally comprises up to 4 heteroatoms selected from N, O, or S, and wherein a CH2 adjacent to said N, O or S maybe substituted with C(O); and each R14 optionally comprises up to 2 substituents independently chosen from H, (C1-C4)-straight or branched alkyl, or (C2-C4) straight or branched alkenyl, 1,2-methylenedioxy, 1,2-ethylenedioxy, or (CH2)n-Z;
wherein Z is selected from halogen, CN, NO2, CF3, OCF3, OH, S(C1-C4)-alkyl, SO(C1-C4)-alkyl, SO2(C1-C4)-alkyl, NH2, NH(C1-C4)-alkyl, N((C1-C4)-alkyl)2, N((C1-C4)-alkyl)R15, COOH, C(O)O(C1-C4)-alkyl or O(C1-C4)-alkyl;
wherein n is 0, 1, 2, 3, or 4; and
wherein R15 is an amino protecting group; and
wherein any carbon atom in any R13 is optionally replaced by O, S, SO, SO2, NH, or N(C1-C4)-alkyl.

### Claim 34 (depends on 33)

The process according to claim 33, wherein said process comprises one or more of the following:
in step (a) said phosgene reagent is about a 10% to about a 30% solution of phosgene in toluene; said suitable conditions comprise a suitable solvent selected from a nonpolar aprotic solvent; a suitable organic base; a suitable reaction atmosphere; a suitable reaction temperature; and a suitable reaction time; and
in step (b) said suitable conditions comprise a suitable solvent selected from a protic solvent, an aprotic solvent, or mixtures thereof; a suitable inorganic or organic base; a suitable reaction atmosphere; a suitable reaction temperature; and a suitable reaction time.

### Claim 35 (depends on 34)

The process according to claim 34, wherein said process comprises one or more of the following:
in step (a) said phosgene reagent is about a 20% solution of phosgene in toluene; said nonpolar aprotic solvent is benzene or toluene; said organic base is pyridine; said suitable reaction atmosphere is nitrogen or argon; said suitable reaction temperature is between about 20° C. and about 60° C.; and said suitable reaction time is between about 1 hour to about 48 hours;
in step (b) said suitable conditions comprise a suitable solvent mixture; a suitable organic base; a suitable reaction atmosphere; a suitable reaction temperature; and a suitable reaction time; and said suitable solvent mixture comprises a mixture of a protic solvent and an aprotic solvent wherein said protic solvent is water, and wherein said aprotic solvent is selected ethyl acetate, isopropyl acetate, n-butyl acetate, benzene, toluene, xylene, dichloromethane, dichloroethane, chloroform, trifluorotoluene, ethyl ether, isopropyl ether, or methyl t-butyl ether; said inorganic base is selected from Na2CO3, K2CO3, Cs2CO3, Li2CO3, NaHCO3, KHCO3, NaOH, KOH, LiOH; said reaction atmosphere is selected from air, nitrogen or argon; said reaction temperature is between about 20° C. and about 80° C.; and said reaction time is between about 30 minutes to about 24 hours.

### Claim 36 (depends on 33)

The process according to claim 33, wherein:
X1 is chlorine.

### Claim 37 (depends on 33)

The process according to claim 33, wherein:
y is zero;
R1 and R2 are taken together to form a 3-tetrahydrofuranyl moiety; and
R9 is hydrogen, or (S)-methyl.

### Claim 38 (depends on 33)

The process according to claims 33, wherein:
R1 or R2 is selected from hydrogen, methyl, ethyl or phenyl; and the other of R1 or R2 is selected from —CH2OH, —CH2CN, —CH2CH2CN, or —CH2N(CH2CH3)2; and
R9 is hydrogen or (S)-methyl.

### Claim 39

A compound of formula Va:
or a salt thereof, wherein:
Q is NO2 or NH2;
each of R1 and R2 is independently selected from hydrogen; —CF3; —(C1-C6)-straight or branched alkyl; —(C2-C6)-straight or branched alkenyl or alkynyl; —(C1-C6)-straight or branched alkyl-R7; —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7 or —R7; and wherein at least one of R1 or R2 is —(C1-C6)-straight or branched alkyl-R7; —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7 or —R7;
wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by R3; or
R1 and R2 are alternatively taken together to form a tetrahydrofuran ring, wherein up to 2 hydrogen atoms in said tetrahydrofuran ring are optionally replaced by —OR6 or —R7;
each R3 is independently selected from halogen, CN, —OR4, or —N(R5)2;
R4 is selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl, —[(C1-C6)-straight or branched alkyl]-R7, —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7, —C(O)-[(C1-C6)-straight or branched alkyl], —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl], —C(O)-[(C1-C6)-straight or branched alkyl]-N(R8)2, —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl]-N(R8)2, —P(O)(OR8)2, —P(O)(OR8)(R8), —C(O)—R7, —S(O)2N(R5)2, —[(C1-C6)-straight or branched alkyl]-CN, or —[(C2-C6)-straight or branched alkenyl or alkynyl]-CN;
wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by —C═O or Y;
Y is selected from halogen, CN, NO2, CF3, OCF3, SR8, S(O)R8, SO2R8, NHR3, N(R8)2, COOR8 or OR8;
each R5 is independently selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl, —[(C1-C6)-straight or branched alkyl]-R7, —[(C2-C6)-straight or branched alkenyl or alkynyl]-R7, —[(C1-C6)-straight alkyl]-CN, —[(C2-C6)-straight or branched alkenyl or alkynyl]-CN, —[(C1-C6)-straight or branched alkyl]-OR4, —[(C2-C6)-straight or branched alkenyl or alkynyl]-OR4, —C(O)—(C1-C6)-straight or branched alkyl, —C(O)-[(C2-C6)-straight or branched alkenyl or alkynyl], —C(O)—R7, —C(O)O—R7, —C(O)O—(C1-C6)-straight or branched alkyl, —C(O)O—[(C2-C6)-straight or branched alkenyl or alkynyl], —S(O)2—(C1-C6)-straight or branched alkyl, or —S(O)2—R7; or two R5 moieties, when bound to the same nitrogen atom, are taken together with said nitrogen atom to form a 3 to 7-membered heterocyclic ring, wherein said heterocyclic ring optionally contains 1 to 3 additional heteroatoms independently selected from N, O, S, S(O) or S(O)2;
wherein up to 4 hydrogen atoms in any of said alkyl, alkenyl or alkynyl are optionally and independently replaced by —C═O or Y;
R6 is selected from —C(O)—CH3, —CH2—C(O)—OH, —CH2—C(O)—O-tBu, —CH2—CN, or —CH2—C≡CH; each R7 is a monocyclic or bicyclic ring system wherein in said ring system:
i. the ring comprises 5 to 7 ring atoms independently selected from C, N, O or S;
ii. no more than 4 ring atoms are selected from N, O or S;
iii. any CH2 is optionally replaced with C(O);
iv. any S is optionally replaced with S(O) or S(O)2; and
v. up to 3 hydrogen atoms in said monocyclic ring system are optionally replaced by V1;
each R8 is independently selected from hydrogen, —(C1-C4)-straight or branched alkyl, or —(C2-C4)-straight or branched alkenyl;
wherein up to 4 hydrogen atoms in any of said alkyl or alkenyl are optionally and independently replaced by halogen, CN, NO2, CF3, OCF3, SR17, S(O)R17, SO2R17, NHR17, N(R17)2, COOR17 or OR17;
wherein R17 is selected from hydrogen, —(C1-C6)-straight or branched alkyl, —(C2-C6)-straight or branched alkenyl or alkynyl;
R9 is selected from hydrogen, or —(C1-C6)-straight or branched alkyl or (C3-C6)-cycloaliphatic;
wherein up to 4 hydrogen atoms in any of said alkyl, or cycloaliphatic are optionally and independently replaced by —C═O or Y;
provided that;
(a) when R1 is hydrogen and R2 is CH2Ph, then R9 is not CH2OR8, CH2CO2R8, CO2R8, CN, or C(O)NH2; and
provided that the following compound are excluded;
(b) methyl 2-(methoxycarbonyl)-1-(3-nitrophenyl) allylcarbamate;
(c) methyl 2-hydroxy-1-(3-nitrophenyl)propylcarbamate;
(d) allyl 2-(ethoxycarbonyl)-1-(3-nitrophenyl)ethylcarbamate;
(e) ethyl cyano(3-nitrophenyl)methylcarbamate; and
(f) ethyl 2-(ethoxycarbonyl)-1-(3-nitrophenyl)-3-oxobutylcarbamate.

### Claim 40 (depends on 39)

The compound according to claim 39, wherein;
R1 and R2 are taken together to form a 3-tetrahydrofuranyl ring; and
R9 is hydrogen.

### Claim 41 (depends on 39)

The compound according to claim 39, wherein;
R1 or R2 is selected from hydrogen, methyl, ethyl or phenyl; and the other of R1 or R2 is selected from —CH2OH, —CH2CN, —CH2CH2CN, or —CH2N(CH2CH3)2; or wherein R1 and R2 are taken together to form a 3-tetrahydrofuranyl moiety; and
R9 is hydrogen, (S)-methyl, (S)-ethyl, or (S)-hydroxymethyl.

### Claim 42 (depends on 41)

The compound according to claim 41, wherein;
R1 or R2 is ethyl; and the other of R1 or R2 is —CH2CN; and
R9 is (S)-methyl.
